Wellspring Financial Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
CIM
ATO
CGH
Wellspring Financial Advisors's GILD Position: Q2 2026 in Review
Wellspring Financial Advisors increased its Gilead Sciences (GILD) stake by 5.4% in Q2 2026, buying an estimated $28.5K and bringing the position to 4,213 shares worth $532K. The position accounts for 0.04% of the portfolio, ranked #160.
Wellspring Financial Advisors first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $557K in Q1 2026. 691 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Wellspring Financial Advisors held 4,213 shares of Gilead Sciences worth $532K as of Q2 2026.
- Wellspring Financial Advisors bought 216 Gilead Sciences shares in Q2 2026, an estimated $28.5K.
- Gilead Sciences made up 0.04% of Wellspring Financial Advisors's portfolio in Q2 2026, its #160 holding.
- Wellspring Financial Advisors first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
- Wellspring Financial Advisors's Gilead Sciences position peaked at $557K in Q1 2026.
- 691 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Wellspring Financial Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.